LIQUIDIA CORP (LQDA) Stock Price, Quote, News and Overview
NASDAQ:LQDA - Nasdaq - US53635D2027 - Common Stock - Currency: USD
LQDA Quote, Performance and Key Statistics
14.82
-0.04 (-0.27%)
The current stock price of LQDA is 14.82 USD. In the past month the price decreased by -7.14%. In the past year, price increased by 5.56%.
LQDA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 66.89 | 824.51B | ||
| JNJ | JOHNSON & JOHNSON | 16.69 | 401.33B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 26.34 | 386.95B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 21.41 | 240.28B | ||
| MRK | MERCK & CO. INC. | 12.39 | 239.09B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.56 | 228.26B | ||
| PFE | PFIZER INC | 8.59 | 151.49B | ||
| SNY | SANOFI-ADR | 14.31 | 148.55B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 53.59 | 123.97B | ||
| GSK | GSK PLC-SPON ADR | 8.34 | 81.62B | ||
| ZTS | ZOETIS INC | 28.78 | 76.29B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 33.71 | 47.88B |
Related stock screener links
About LQDA
Company Profile
Liquidia Corp. operates as a holding company which through its subsidiary engages in developing and commercializing biopharmaceutical products. The company is headquartered in Morrisville, North Carolina and currently employs 136 full-time employees. The company went IPO on 2018-07-26. The firm is focused on the development, manufacture and commercialization of products that address unmet patient needs, with a focus directed towards rare cardiopulmonary diseases, such as pulmonaryarterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The firm operates through its wholly owned operating subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Its proprietary PRINT technology is a particle engineering platform, which enable precise production of uniform drug particles. Its lead product candidate is YUTREPIA for the treatment of PAH and PH-ILD. YUTREPIA is an inhaled dry powder formulation of treprostinil designed with PRINT to improve the therapeutic profile of treprostinil by enhancing deep lung delivery while using a convenient, dry-powder inhaler (DPI) and by achieving higher dose levels than the labeled doses of current inhaled therapies.
Company Info
LIQUIDIA CORP
419 Davis Drive, Suite 100
Morrisville NORTH CAROLINA 27560 US
CEO: Neal Fowler
Employees: 145
Company Website: https://www.liquidia.com/
Investor Relations: http://www.liquidia.com/investors/overview
Phone: 19193284400
LIQUIDIA CORP / LQDA FAQ
What is the stock price of LIQUIDIA CORP today?
The current stock price of LQDA is 14.82 USD. The price decreased by -0.27% in the last trading session.
What is the ticker symbol for LIQUIDIA CORP stock?
The exchange symbol of LIQUIDIA CORP is LQDA and it is listed on the Nasdaq exchange.
On which exchange is LQDA stock listed?
LQDA stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for LIQUIDIA CORP stock?
16 analysts have analysed LQDA and the average price target is 25.84 USD. This implies a price increase of 74.36% is expected in the next year compared to the current price of 14.82. Check the LIQUIDIA CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is LIQUIDIA CORP worth?
LIQUIDIA CORP (LQDA) has a market capitalization of 1.25B USD. This makes LQDA a Small Cap stock.
How many employees does LIQUIDIA CORP have?
LIQUIDIA CORP (LQDA) currently has 145 employees.
What are the support and resistance levels for LIQUIDIA CORP (LQDA) stock?
LIQUIDIA CORP (LQDA) has a support level at 14.81. Check the full technical report for a detailed analysis of LQDA support and resistance levels.
Is LIQUIDIA CORP (LQDA) expected to grow?
The Revenue of LIQUIDIA CORP (LQDA) is expected to decline by -10.25% in the next year. Check the estimates tab for more information on the LQDA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy LIQUIDIA CORP (LQDA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of LQDA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of LQDA, evaluating the profitability, health, valuation and growth aspects
- LIQUIDIA CORP (LQDA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- LIQUIDIA CORP (LQDA) Sales and EPS estimates to see what analysts future expectations are.
- LIQUIDIA CORP (LQDA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- LIQUIDIA CORP (LQDA) Insider and Institutional Ownership to learn about the owners and their transactions.
- LIQUIDIA CORP (LQDA) Stock Chart to make your own analysis
- LIQUIDIA CORP (LQDA) Latest news and press-releases to stay up to date.
Does LIQUIDIA CORP (LQDA) stock pay dividends?
LQDA does not pay a dividend.
When does LIQUIDIA CORP (LQDA) report earnings?
LIQUIDIA CORP (LQDA) will report earnings on 2025-03-13, after the market close.
What is the Price/Earnings (PE) ratio of LIQUIDIA CORP (LQDA)?
LIQUIDIA CORP (LQDA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.63).
What is the Short Interest ratio of LIQUIDIA CORP (LQDA) stock?
The outstanding short interest for LIQUIDIA CORP (LQDA) is 18.72% of its float. Check the ownership tab for more information on the LQDA short interest.
LQDA Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to LQDA. When comparing the yearly performance of all stocks, LQDA is one of the better performing stocks in the market, outperforming 90.38% of all stocks.
LQDA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to LQDA. While LQDA seems to be doing ok healthwise, there are quite some concerns on its profitability.
LQDA Financial Highlights
Over the last trailing twelve months LQDA reported a non-GAAP Earnings per Share(EPS) of -1.63. The EPS decreased by -87.36% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -47.24% | ||
| ROE | -108.1% | ||
| Debt/Equity | 0.9 |
LQDA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 85% to LQDA. The Buy consensus is the average rating of analysts ratings from 16 analysts.
For the next year, analysts expect an EPS growth of -32.6% and a revenue growth -10.25% for LQDA